Interferon-gamma assay in combination with tuberculin skin test are insufficient for the diagnosis of culture-negative pulmonary tuberculosis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Wlodarczyk, Marcin ^a   Rudnicka, Wieslawa ^a   Janiszewska Drobinska, Beata ^b   Kielnierowski, Grzegorz ^b   Kowalewicz Kulbat, Magdalena ^a   Fol, Marek ^a   Druszczynska, Magdalena ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b Regional Specialised Hospital of Tuberculosis Lung Diseases and Rehabilitation   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN;

ADULT; AGE; ARTICLE; BACTERIUM CULTURE; BLOOD CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HOSPITAL PATIENT; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LUNG DISEASE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NON MYCOBACTERIAL LUNG DISEASE; NONHUMAN; POLAND; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; AGED; BLOOD; COMMUNITY-ACQUIRED INFECTIONS; EVALUATION STUDY; IMMUNOLOGY; MIDDLE AGED; TUBERCULOSIS;

ADULT; AGED; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84907158661     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107208     Document Type: Article

References (37)

1. World Health Organization (WHO), Global Tuberculosis Report, 2013. Available: http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656-eng.pdf?ua=1. Accessed 2014 May 30.
2. Huebner RE, Schein MF, Bass JB Jr (1993) The tuberculin skin test. Clin Infect. Dis 17: 968-975.
3. Rangaka MX, Wilkinson KA, Glyn JR, Ling D, Menzies D, et al. (2012) Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 12: 45-55.
4. Dai Y, Feng Y, Xu R, Xu W, Lu W, et al. (2012) Evaluation of interferongamma release assays for the diagnosis of tuberculosis: an updated meta-analysis. Eur J Clin Microbiol Infect Dis. doi: 10.1007/s10096-012-1674-y.
5. Vassilopoulos D, Isikrika S, Hatzara C, Podia V, Kandili A, et al. (2011) Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy. Clin Vaccine Immunol 18: 2102-2108.
6. Onur H, Hatipoglu S, Anca V, Hatipoglu N, Arica SG (2012) Comparison of quantiferon test with tuberculin skin test for the detection of tuberculosis infection in children. Inflammation, 35: 1518-1524.
7. Seyhan EC, Sokucu S, Altin S, Gunluoglu G, Trablus S, et al. (2010) Comparison of the Quanti FERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transpl Infect Dis 12: 98-105.
8. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, et al. (2004) Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 170: 59-64.
9. Ravn P, Munk ME, Andersen AB, Lundgren B, Lundgren JD, et al. (2005) Prospective evaluation of a whole blood test using Mycobacterium tuberculosisspecific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 12: 491-496.
10. Pai M, Menzies D (2007) The new IGRA and the old TST. Am J Respir Crit Care Med 175: 529-530.
11. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177-184.
12. Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, et al. (2013) Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis. Health Technol Assess 17: 1-372, doi: 10.331/hta17370.
13. Siddiqi K, Lambert M-L, Walley J (2003) Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis 3: 288-296.
14. Ling DI, Flores LL, Riley LW, Madhukar P (2008) Commercial nucleic-acidamplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: Meta-analysis and Meta-regression. PLOS One, doi: 10.137/journal.pone.0001536.
15. Dorman SE (2010) New diagnostic tests for tuberculosis: bench, bedside, and beyond. Clin Infect Dis 15: S173-177, doi: 10.1086/651488.
16. Winqvist N, Björkman P, Noren A, Miörer H (2009) Use of a T cell interferon gamma release assay in the investigation for suspected active tuberculosis in a low prevalence area. BMC Infect Dis 3: 105. doi: 10.1186/1471-2334-9-105.
17. Dewan PK, Grinsdale J, Kawamura LM (2007) Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 44: 69-73.
18. Lui G, Lee N, Cheung SW, Lam JSY, Wong BCK, et al. (2011) Interferon gamma release assay for differentiating tuberculosis among pneumonia cases in acute healthcare setting. J Infect 262: 440-447.
19. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, et al. (2011) Interferon-γ release assays for the diagnosis of active tuberculosis: a systemic review and meta-analysis. Eur Respir J 37: 100-111.
20. Ling DI, Pai M, Davids P, Brunet L, Lenders L, et al. (2011) Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting? Eur Respir J 38: 649-659.
21. Kang YA, Lee HW, Hwang SS, Um SW, Han SK, et al. (2007) Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 132: 959-965.
22. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, et al. (2008) Clinical utility of the Quanti FERON TB-2G test for elderly patients with active tuberculosis. Chest 133: 1196-1202.
23. Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, et al. (2007) Prospective comparison of the tuberculin skin test and 2 whole blood interferonc release assays in persons with suspected tuberculosis. CID 45: 837-845.
24. Raby E., Moyo M., Devendra A., Banda J., De Haas P, et al. (2008) The effects of HIV on the sensitivity of a whole blood IFN-γ release assay in Zambian adults with active tuberculosis. PloS ONE, 6: e2489.
25. Chen J, Zhang R, Wang J, Liu L, Zheng Y, et al. (2011) Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systemic review and meta-analysis. PloS ONE 6: e26827.
26. Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, et al. (2008) Aging of the immune system as a prognostic factor for human longevity. Physiology 23: 64-74.
27. Ottenhoff THM (2012) New pathways of protective and pathological host defense to mycobacteria. Trends in Microbiology 20: 419-428.
28. Andersen P, Doherty TM, Pai M, Weldingh K (2007) The prognosis of latent tuberculosis: can disease be predicted? Trends in Molecular Medicine 13: 175-182.
29. Dlugowitzky D, Torres-Morales A, Rateni L, Farroni MA, Largacha C, et al. (1997) Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol Med Microbiol 18: 203-207.
30. Sharma SK, Mitra DK, Balamurugan A, Pandey RM, Mehra NK (2002) Cytokine polarization in miliary and pleural tuberculosis. J Clin Immunol 22: 345-352.
31. Hasan Z, Jamil B, Ashraf M, Islam M, Yusuf MS, et al. (2009) ESAT6-induced IFN-γ and CXCL9 can differentiate severity of tuberculosis. PloS ONE 4: e5158.
32. Andersen P, Askgaard D, Ljungqvist L, Bentzon MW, Heron I (1991) T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun 59: 1558-1563.
33. Winslow GM, Roberts AD, Blackman MA, Woodland DL (2003) Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J Immunol 170: 2046-2052.
34. Brodin P, Majlessi L, Marsollier L, de Jonge MI, Bottai D, et al. (2006) Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun 74: 88-98.
35. Buddle BM, Parlane NA, Keen DL, Aldwell FE, Pollock JM, et al. (1999) Differentiation between Mycobacterium bovis BCG-vaccinated and M.bovisinfected cattle by using recombinant mycobacterial antigens. Clin Diagn Lab Immunol 6: 1-5.
36. Vordermeier HM, Chambers MA, Cockle PJ, Whelan AO, Simmons J, et al. (2002) Correlation of ESAT-6-specific γ interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun 70: 3026-3032.
37. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, et al. (2002) Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 40: 704-706.